About Nexo Therapeutics
Nexo Therapeutics is a private company based in Littleton, Colorado, incorporated in 2022 in Delaware. It has reported $60,000,000 raised in one offering on Form D since November 2022. Its chief executive is Andrew Phillips.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 15, 2022 | Nov 21, 2022amended Mar 27, 2026 | $60,000,000fully sold | 7 | $8.5M | Equity, DebtRule 506(b) | Form D/A ↗3 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nexo Therapeutics's Form D filed Mar 27, 2026.
AB
Ali Behbahani
Partner, Co-Head of Healthcare, NEA and director
Andrew Phillips
President and Chief Executive Officer, director
CR
Carlo Rizzuto
Managing Director, Versant Ventures